Adma Biologics reported $1.09M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Adma Biologics USD 1.09M 717K Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Novavax USD 303K 27K Dec/2021
Takeda JPY 24.61B 213.76B Jun/2026